Akademik Veri Yönetim Sistemi
Clinical and Applied Thrombosis/Hemostasis, cilt.23, sa.3, ss.235-240, 2017 (SCI-Expanded)
In-stent restenosis (ISR) is a common clinical problem in patients with coronary artery disease treated with percutaneous coronary intervention. Inflammatory process plays a pivotal role in the development of ISR. Both lymphocytes and monocytes are associated with inflammatory status. Recently, it has been shown that the lymphocyte-to-monocyte ratio (LMR) is a novel inflammatory marker. We aimed to investigate the association of serum LMR levels and ISR in patients undergoing bare-metal stent (BMS) implantation. The study included 273 patients (aged 61 ± 11 years, 66.5% men) with a history of BMS implantation and a further control coronary angiography due to stable angina pectoris. Patients were divided into 2 groups: patients with and without ISR. The LMR levels were significantly lower in patients with ISR than in those without ISR (2.50 ± 0.95 vs 3.87 ± 1.51, respectively, P <.001). On multivariate logistic regression analysis, the LMR was independently associated with ISR (odds ratio [OR]: 0.310, 95% confidence interval: 0.166-0.579, P <.001) together with high-sensitivity C-reactive protein (OR: 1.244, P =.008), reason for stent implantation (OR: 6.566, P =.003), stent diameter (OR: 0.015, P <.001), and stent length (OR: 1.137, P =.007). In conclusion, LMR levels are inversely related to ISR in patients treated with BMS implantation.